SCHEMBL19924840

SCHEMBL19924840

N[C@H](C=O)N1CCC(O)CC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.32
DPP4 P27487 4/20 0.31
DPP7 Q9UHL4 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5521124 0.76 GPR119 (0.33) GPR119
SCHEMBL27861037 0.74 GPR119 (0.32) GPR119DPP4
SCHEMBL6658943 0.74 GPR119 (0.32) GPR119
SCHEMBL3716933 0.74
SCHEMBL15955662 0.72 DPP7 (0.38) DPP7
SCHEMBL16335754 0.72 DPP7 (0.38) DPP7
Hydrochloric Acid SCHEMBL16992665 0.72 DPP7 (0.33) DPP7
SCHEMBL7459218 0.71 NOTUM (0.38)
SCHEMBL24734683 0.70 DPP4 (0.37) GPR119DPP4
SCHEMBL8891712 0.69 KCNH2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507281-A1 IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISEASES OR CANCERS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2019-07-10 EP disclosed
WO-2018041964-A1 IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISEASES OR CANCERS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2018-03-08 WO disclosed